Detailed data on AstraZeneca-Oxford Covid-19 vaccine show it has moderate efficacy

The Covid-19 vaccine being developed by the University of Oxford and AstraZeneca appears to have moderate efficacy in preventing symptomatic illness, and may significantly reduce hospitalization from the disease, data from four clinical trials of the vaccine reveal.